This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group (UNH) Ascends But Remains Behind Market: Some Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $606.79, denoting a +0.16% change from the preceding trading day.
Recalculation Ahead: Implications of UnitedHealth's Win Against CMS
by Kaibalya Pravo Dey
UNH's success marks the third recent defeat for CMS in star ratings lawsuits, raising hopes for Humana and Centene as they challenge their own ratings.
Why Is Molina (MOH) Down 8.5% Since Last Earnings Report?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UnitedHealth Group (UNH) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $589.65, marking a -0.44% move from the previous day.
UnitedHealth Stock Up 12.7% YTD: Is its Premium Valuation Justified?
by Kaibalya Pravo Dey
UNH and the broader health insurance industry will likely focus on cost-cutting initiatives and lobbying for better government reimbursement rates over time.
UnitedHealth (UNH) Up 6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog UnitedHealth, Bank of America and SAP SE
by Zacks Equity Research
UnitedHealth, Bank of America and SAP SE are included in this Analyst Blog.
Top Analyst Reports for UnitedHealth, Bank of America & SAP
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Bank of America Corporation (BAC) and SAP SE (SAP).
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal
by Zacks Equity Research
The DOJ suggests that UNH's acquisitions reflect a strategy of buying competitors rather than competing directly, potentially giving it control over multiple markets.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Stocks and ETFs in Focus as Americans Head to Polls
by Sweta Killa
Let's discuss the sectors and ETFs that are the potential gainers or losers as Americans head to the polls, which indicate a tight race between Harris and Trump.
Encompass Health Q3 Earnings Beat on Higher Discharges, Stock Up 6.3%
by Zacks Equity Research
EHC's third-quarter results benefit from improved patient discharges. Higher operating expenses act as a partial offset.
Ensign Group Q3 Earnings Beat on Patient Days, Stock Up 4.1%
by Zacks Equity Research
ENSG's strong third-quarter earnings benefit from improved occupancy and skilled mix days. Higher expenses partially offset the positives.
Cigna Q3 Earnings Beat on Client Wins & Specialty Business Strength
by Zacks Equity Research
CI's strong third-quarter results benefit from a strong Evernorth Health Services segment. Higher expenses partially offset the positives.
Centene Q3 Earnings Beat on Growth in Marketplace Business Line
by Zacks Equity Research
CNC's Q3 results benefit from growth in premiums, driven by strong product positioning. Despite higher revenues, declines in Medicaid membership and increased expenses weigh on profitability.
Universal Health Q3 Earnings Miss on Elevated Operating Costs
by Zacks Equity Research
UHS' Q3 results suffer from rising operating costs in salaries, wages and benefits, and supplies, impacting profitability. Nevertheless, strong revenue growth and increased admissions partly offset the downside.
HCA Healthcare Beats on Q3 Earnings, Reaffirms 2024 EPS View
by Zacks Equity Research
HCA's quarterly results benefit from improved admissions and inpatient surgeries, partially offset by the impact of hurricanes and rising salaries and benefits expenses.
The Zacks Analyst Blog Highlights Alphabet, UnitedHealth, Chubb, Key Tronic and Massimo
by Zacks Equity Research
Alphabet, UnitedHealth, Chubb, Key Tronic and Massimo are included in this Analyst Blog.
Top Research Reports for Alphabet, UnitedHealth & Chubb
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), UnitedHealth Group Incorporated (UNH) and Chubb Limited (CB), as well as two micro-cap stocks Key Tronic Corporation (KTCC) and Massimo Group (MAMO).
Molina Healthcare Q3 Earnings Beat Estimates on Growing Premiums
by Zacks Equity Research
MOH's third-quarter results benefit from growing membership and rising premiums, partially offset by rising expenses.
Community Health Q3 Earnings Miss on Lower Adjusted Admissions
by Zacks Equity Research
CYH's third-quarter earnings suffer a setback due to lower admissions and patient days. Improved occupancy levels and reimbursement rates partially offset the negatives.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Beyond UnitedHealth's Q3 Earnings: Time to Reevaluate & Sell Stock?
by Kaibalya Pravo Dey
Looking ahead to 2025, UNH projects adjusted earnings to reach around $30 per share at the top end, which falls short of the Zacks Consensus Estimate.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC